Navigation Links
Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
Date:2/22/2010

Revenue $21 $28 $101 $111 Operating expenses: Research and development 19,974 10,755 61,586 50,086 General and administrative 16,430 4,783 38,556 20,503 ------ ----- ------ ------ Total operating expenses 36,404 15,538 100,142 70,589 ------ ------ ------- ------ Loss from operations (36,383) (15,510) (100,041) (70,478) Interest income 239 712 964 3,619 Interest expense (390) (1,161) (2,321) (5,156) Gain (Loss) from valuation of warrant liability 4,025 7,122 (118,763) 371 ----- ----- -------- --- Net loss ($32,509) ($8,837) ($220,161) ($71,644) ======== ======= ========= ======== Basic and diluted net loss per share ($0.28) ($0.09) ($2.04) ($0.79) ====== ====== ====== ======
'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
2. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
3. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
4. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
5. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
6. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
7. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
8. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
9. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
10. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
11. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... BROOKFIELD, Wis. , March 27, 2015 /PRNewswire/ ... 40,000 unit shipments of incontinence devices for women. ... terrific, but the most gratifying part is the ... receive from women whose lives have been positively ... , president of InControl. InControl recently ...
(Date:3/27/2015)... 27, 2015 RnRMarketResearch.com adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... Pa., Oct. 22 Cephalon, Inc. (Nasdaq: ... Strategies (REMS) for its medications NUVIGIL® (armodafinil) Tablets [C-IV] ... the U.S. Food and Drug Administration (FDA).  Both the ... to inform patients about the potential risks associated with ...
... China, Oct. 22 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation ... Medicine" or "the Company"), a leading manufacturer, developer ... ("TCM"), and other health products, today announced that ... financial results after market close on Wednesday, November ...
Cached Medicine Technology:Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 2Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 3Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL 4
(Date:3/28/2015)... Centurion Service Group will be hosting a live ... at their Las Vegas warehouse, located at 4606 Andrews St. ... consists of equipment from hospitals and surgery centers from around ... , Buyers will find items of all types including ... one-stop-shop,” said Erik Tivin, CEO of Centurion. , Among the ...
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... 28, 2015 Healthpointe’s otolaryngologists, medical practitioners ... throat disorders, are now offering a wide variety ... which is characterized by the presence of phantom sounds ... people, tinnitus is a prevalent symptom that can arise ... is non-fatal, tinnitus can impede a person’s quality of ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... FL (PRWEB) March 27, 2015 Florida Hospital ... Storm as the team’s exclusive health care provider for the ... provider, Florida Hospital provides medical care and an athletic trainer ... Storm will kick off its season against the Cleveland Gladiators ... , “This partnership is extremely important to us as it ...
Breaking Medicine News(10 mins):Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3
... M. Jackson Foundation for the Advancement of Military Medicine, ... the Health Sciences (USU) doctoral students to receive fellowships ... 1988, includes two Henry M. Jackson Fellowships and one ... and travel support. Jeremy Gilbreath, a ...
... A broad panel of leaders representing health care, academic ... in the content and format of U.S. graduate medical ... effectively and efficiently to meet public needs. ... for overhauling the training of newly minted physicians - ...
... of the University of California and a Southern California ... commercialize their ideas for new, lower cost health care ... affordable and efficient chronic disease management and preventive health ... is led by the von Liebig Entrepreneurism Center at ...
... health plans nationally may benefit consumers by lowering hospital ... are the most consolidated, according to a new RAND ... about 12 percent lower in the metropolitan areas ... view that when health plans become bigger they can ...
... usually reserved for designing buildings, bridges and aircraft has ... cancer patients. In a study published today, ... , researchers used computer-aided design (CAD) to create an ... as a visual aid to surgeons in tissue reconstruction ...
... ROCHESTER, Minn. -- A study by Mayo Clinic physician and ... Sandhya Pruthi, M.D. , and colleagues found that flaxseed ... among breast cancer patients and postmenopausal women. The study is ... Menopause . The randomized, placebo-controlled study followed ...
Cached Medicine News:Health News:HJF names 2011-12 fellowship award winners 2Health News:Macy Foundation report calls for sweeping graduate medical education reforms 2Health News:Macy Foundation report calls for sweeping graduate medical education reforms 3Health News:Macy Foundation report calls for sweeping graduate medical education reforms 4Health News:Accessible and affordable care at heart of health-care technology grants 2Health News:Accessible and affordable care at heart of health-care technology grants 3Health News:Accessible and affordable care at heart of health-care technology grants 4Health News:Accessible and affordable care at heart of health-care technology grants 5Health News:Accessible and affordable care at heart of health-care technology grants 6Health News:Accessible and affordable care at heart of health-care technology grants 7Health News:Consolidation of health plans may help lower hospital costs, study finds 2Health News:Computer-aided design used for breast tissue reconstruction 2Health News:Flaxseed no help for hot flashes during breast cancer or menopause, study finds 2
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... assay was originally developed for the World ... ovarian function. It has been widely used ... of natural family planning methods. Urine samples ... concentration measured by EIA (enzyme labelled immunoassay ...
... 10-8700 ACTIVE® Estrone Enzyme Immunosorbent Assay ... quantitative measurement of Estrone in serum. ... of enzyme immunoassay where there is ... an enzyme-labeled antigen for a fixed ...
Medicine Products: